Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
Authors
Keywords
Drug discovery, Development, Imidazole, Benzimidazole, Medicinal chemistry
Journal
MEDICINAL CHEMISTRY RESEARCH
Volume 25, Issue 2, Pages 173-210
Publisher
Springer Nature
Online
2015-12-31
DOI
10.1007/s00044-015-1495-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
- (2016) Rudolf Weide Therapeutics and Clinical Risk Management
- Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
- (2015) Andreas H. Diacon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review
- (2015) Geeta Yadav et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
- (2015) Angie M. Jarrad et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Development of Galeterone (TOK-001 or VN/124-1) for the Treatment of All Stages of Prostate Cancer
- (2015) Vincent C. O. Njar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzimidazole derivatives: search for GI-friendly anti-inflammatory analgesic agents
- (2015) Monika Gaba et al. Acta Pharmaceutica Sinica B
- In VitroandIn VivoActivities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis
- (2014) A. M. Upton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies
- (2014) Antoine Tarral et al. CLINICAL PHARMACOKINETICS
- Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents
- (2014) Monika Gaba et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitory effect of the selective serotonin 5-HT3 receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats
- (2014) Mari Nakata-Fukuda et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Synthesis and Biological Evaluation of New Carbohydrate-Substituted Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan (LMP776)
- (2014) Daniel E. Beck et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial
- (2013) A. Vahlquist et al. BRITISH JOURNAL OF DERMATOLOGY
- New substituted benzimidazole derivatives: a patent review (2010 – 2012)
- (2013) Fan Fei et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Proxyfan acts as a neutral antagonist of histamine H3receptors in the feeding-related hypothalamic ventromedial nucleus
- (2012) RH Clapp et al. BRITISH JOURNAL OF PHARMACOLOGY
- Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
- (2012) Shin-ichiro Miura et al. HYPERTENSION RESEARCH
- Histamine H3 Receptor Function and Ligands: Recent Developments
- (2012) Mahaveer Singh et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Synthesis and Histamine H3 and H4 Receptor Activity of Conformationally Restricted Cyanoguanidines Related to UR-PI376
- (2011) Roland Geyer et al. ARCHIV DER PHARMAZIE
- Design, Synthesis and Antifungal Activity of Some New Imidazole and Triazole Derivatives
- (2011) Zahra Rezaei et al. ARCHIV DER PHARMAZIE
- Ciproxifan, a histamine H3-receptor antagonist / inverse agonist, modulates methamphetamine-induced sensitization in mice
- (2011) Mouhammad Motawaj et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
- (2011) David DeRemer et al. Cancer Management and Research
- Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists—A perspective
- (2010) Prashant Naik et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Histamine H4 receptor agonists
- (2010) Patrick Igel et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bendamustine: something old, something new
- (2010) Nishant Tageja et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system
- (2010) Christopher R. Emerson et al. CLINICAL THERAPEUTICS
- Synthesis and pharmacological evaluation of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives as anti-inflammatory and analgesic agents
- (2010) Monika Gaba et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety
- (2010) Yusuf Özkay et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biological importance of imidazole nucleus in the new millennium
- (2010) Balasubramanian Narasimhan et al. MEDICINAL CHEMISTRY RESEARCH
- Histamine H4 Receptor: A Novel Therapeutic Target for Immune and Allergic Responses
- (2010) H. G. Bhatt et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Histamine H3and H4receptors as novel drug targets
- (2009) Ekaterini Tiligada et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Long-lasting inhibitors of the gastric H,K-ATPase
- (2009) Jai Moo Shin et al. Expert Review of Clinical Pharmacology
- Histamine H3 Receptor Antagonists Go to Clinics
- (2008) Kerstin Sander et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing
- (2008) Clifford D. Jones et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine
- (2008) Ahmed F. Hawwa et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Proton pump inhibitors: the beginning of the end or the end of the beginning?
- (2008) C SCARPIGNATO et al. CURRENT OPINION IN PHARMACOLOGY
- Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer
- (2008) Thomas D. Penning et al. JOURNAL OF MEDICINAL CHEMISTRY
- The 5-HT3 receptor – the relationship between structure and function
- (2008) Nicholas M. Barnes et al. NEUROPHARMACOLOGY
- The gastric HK-ATPase: structure, function, and inhibition
- (2008) Jai Moo Shin et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells
- (2007) Lei Sun et al. BIOCHEMICAL PHARMACOLOGY
- Histamine and its receptors
- (2006) Mike E Parsons et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started